Beware of False “Cures” for Autism

What you need to know

Unapproved and Potentially Harmful Products

Autism Spectrum Disorder (ASD) affects about 1 in 68 children, and while early behavioral therapies can help improve symptoms, there is no cure for autism. Unfortunately, some companies promote unproven products that falsely claim to treat or even cure ASD — and some can be dangerous.

What the FDA Wants You to Know

The FDA has acted against companies marketing unapproved and potentially harmful products that claim to treat autism. These include:

  • Chelation Therapies (sprays, drops, baths): Meant to remove “toxins,” but can dangerously deplete essential minerals.
  • Hyperbaric Oxygen Chambers: Only approved for specific medical uses — not autism.
  • Detoxifying Clay Baths: Claim to “pull out toxins” through the skin — no evidence they help.
  • MMS (chlorine dioxide), raw camel milk, essential oils, and others: Heavily marketed, not scientifically proven, and can pose real health risks.

FDA-Approved Treatments Exist — But Only for Specific Symptoms

There are two FDA-approved medications to manage irritability associated with autism:

  • Risperidone (ages 5–16)
  • Aripiprazole (ages 6–17)

These medications help with specific symptoms — not autism itself — and should only be used under medical supervision.

Real Help for ASD

  • Early behavioral interventions can improve communication and daily living skills.
  • Treatment should be tailored to the individual’s needs.
  • Work with licensed healthcare professionals, not unregulated products.

Watch Out for These Red Flags

  • “Quick fixes” or “miracle cures”
  • Claims to treat a wide range of unrelated conditions
  • Personal stories with no scientific backing
  • Secret ingredients or “breakthrough science”

If it sounds too good to be true, it probably is.

If you have questions about therapies or treatments, talk to a doctor who specializes in autism. Trust science — not sales pitches.

Read more here

FDA Issues Warning on Counterfeit Botox Products 

Real Botox PackagingReal Botox Cosmetic PackagingReal Botox PackagingCounterfeit Botox Products  The U.S. Food and Drug Administration (FDA) has issued a critical alert concerning the presence of counterfeit Botox products in various states, posing severe risks to...

FDA Approves XACT Carotid Stent System

A Breakthrough for Stroke Prevention  Abbott Vascular Inc. has received FDA approval for its groundbreaking XACT Carotid Stent System, a significant advancement in stroke prevention technology. Approved on February 7, 2024, this innovative system offers new hope for...

FDA Approves Xolremdi for WHIM Syndrome 

A Breakthrough for Rare Infections  In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted approval for Xolremdi (mavorixafor) capsules, marking a significant milestone in the treatment of WHIM syndrome. Let's delve into what this...